Le vaccin, un médicament devenu l’arme absolue promise contre la COVID-19: une réglementation adaptée?

Resume Alors que les premiers vaccins contre la COVID-19 arrivent sur le marche, la question de la securite de ces produits emerge dans le debat public L’inquietude majeure porte sur l’apparition possible d’effets indesirables, notamment dans le cadre de l’utilisation de technologies pharmaceutiques inedites a l’instar de l’ARNm Il est important de rappeler aux patients comme aux professionnels qu’un vaccin est non seulement un medicament a part entiere, mais aussi un medicament special : biologique et immunologique En consequence, son encadrement est draconien, et malgre l’urgence, aucune exigence n’a ete revue la baisse La rapidite de mise sur le marche resulte tant des essais cliniques adaptes que de procedures d’evaluation optimisees As the first vaccines against COVID-19 arrive on thse market, the question of the safety of these products arises in the public debate The major concern is about the possible occurrence of adverse effects, particularly in the context of the use of novel pharmaceutical technologies such as mRNA It is important to remind both patients and professionals that a vaccine is not only a medicinal product in its own right, but also a special medicinal product: biological and immunological As a result, its supervision is draconian, and despite the urgency, no requirements have been lowered The speed of marketing is the result both of adapted clinical trials and optimized evaluation procedures